Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice

Toxoplasmosis, one of the most important health-threatening diseases worldwide, is caused by Toxoplasma gondii, which infects a wide range of warm-blooded animals and humans, leading to enormous health and socioeconomic concerns. T. gondii can establish chronic infection to evade the immune response...

Full description

Bibliographic Details
Main Authors: Wen-Bin Yang, Jin-Lei Wang, Qian Gui, Yang Zou, Kai Chen, Qing Liu, Qin-Li Liang, Xing-Quan Zhu, Dong-Hui Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01875/full
_version_ 1818579113307275264
author Wen-Bin Yang
Wen-Bin Yang
Wen-Bin Yang
Jin-Lei Wang
Qian Gui
Yang Zou
Kai Chen
Qing Liu
Qin-Li Liang
Xing-Quan Zhu
Xing-Quan Zhu
Dong-Hui Zhou
author_facet Wen-Bin Yang
Wen-Bin Yang
Wen-Bin Yang
Jin-Lei Wang
Qian Gui
Yang Zou
Kai Chen
Qing Liu
Qin-Li Liang
Xing-Quan Zhu
Xing-Quan Zhu
Dong-Hui Zhou
author_sort Wen-Bin Yang
collection DOAJ
description Toxoplasmosis, one of the most important health-threatening diseases worldwide, is caused by Toxoplasma gondii, which infects a wide range of warm-blooded animals and humans, leading to enormous health and socioeconomic concerns. T. gondii can establish chronic infection to evade the immune response in hosts. Once a chronic infection has been established, the available treatments cannot efficiently control this stage of T. gondii efficiently. Moreover, the available treatments rely only on a few drugs, such as sulfapyridine and pyrimethamine, that tend to have severe side effects. Given these factors, vaccination has been considered to be the most efficient method to prevent and control this disease. However, there is currently lack of effective vaccine available for use to prevent toxoplasmosis apart form Toxovax®, the only available vaccine, which is used in sheep to prevent abortion. To address this problem, we knocked out the NPT1 gene of the type I T. gondii strain using the CRISPR-Cas9 system, constructed a live-attenuated vaccine and evaluated its protective efficacy in a mouse model. Immunization of mice with RH:ΔNPT1 induced a high level of Toxoplasma-specific IgG1, IgG2a and total IgG 42 days after immunization. There was a significant increase in the levels of cytokines in the splenocyte suspensions of RH:ΔNPT1-infected mice, and a mixed Th1/Th2 response was induced in the mice. Remarkably, after heterologous challenges with tachyzoites of the RH, PYS and Pru strains and cysts of the Pru strain by different infection routes, the immunized animals were protected from toxoplasmosis with a 100% survival rate, in both acute and chronic infection. In addition, compared with control mice, the Pru cyst load was clearly reduced in the brains of RH:ΔNPT1-infected immunization-mice. Our study demonstrated that the RH:ΔNPT1 strain was able to evoke strong anti-Toxoplasma immune responses and provide effective protection against parasite strains with different levels of virulence, suggesting that the RH:ΔNPT1 strain may represent a promising live-attenuated vaccine against toxoplasmosis, which is worthy of further evaluation in food-producing animals and in definitive feline host.
first_indexed 2024-12-16T06:56:32Z
format Article
id doaj.art-c1623f6514874c7a8cfad60881ebd9d2
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-16T06:56:32Z
publishDate 2019-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-c1623f6514874c7a8cfad60881ebd9d22022-12-21T22:40:17ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-08-011010.3389/fmicb.2019.01875466253Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in MiceWen-Bin Yang0Wen-Bin Yang1Wen-Bin Yang2Jin-Lei Wang3Qian Gui4Yang Zou5Kai Chen6Qing Liu7Qin-Li Liang8Xing-Quan Zhu9Xing-Quan Zhu10Dong-Hui Zhou11Key Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaDepartment of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University, Shanghai, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaDepartment of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University, Shanghai, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaCollege of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, ChinaJiangsu Co-innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaKey Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, ChinaToxoplasmosis, one of the most important health-threatening diseases worldwide, is caused by Toxoplasma gondii, which infects a wide range of warm-blooded animals and humans, leading to enormous health and socioeconomic concerns. T. gondii can establish chronic infection to evade the immune response in hosts. Once a chronic infection has been established, the available treatments cannot efficiently control this stage of T. gondii efficiently. Moreover, the available treatments rely only on a few drugs, such as sulfapyridine and pyrimethamine, that tend to have severe side effects. Given these factors, vaccination has been considered to be the most efficient method to prevent and control this disease. However, there is currently lack of effective vaccine available for use to prevent toxoplasmosis apart form Toxovax®, the only available vaccine, which is used in sheep to prevent abortion. To address this problem, we knocked out the NPT1 gene of the type I T. gondii strain using the CRISPR-Cas9 system, constructed a live-attenuated vaccine and evaluated its protective efficacy in a mouse model. Immunization of mice with RH:ΔNPT1 induced a high level of Toxoplasma-specific IgG1, IgG2a and total IgG 42 days after immunization. There was a significant increase in the levels of cytokines in the splenocyte suspensions of RH:ΔNPT1-infected mice, and a mixed Th1/Th2 response was induced in the mice. Remarkably, after heterologous challenges with tachyzoites of the RH, PYS and Pru strains and cysts of the Pru strain by different infection routes, the immunized animals were protected from toxoplasmosis with a 100% survival rate, in both acute and chronic infection. In addition, compared with control mice, the Pru cyst load was clearly reduced in the brains of RH:ΔNPT1-infected immunization-mice. Our study demonstrated that the RH:ΔNPT1 strain was able to evoke strong anti-Toxoplasma immune responses and provide effective protection against parasite strains with different levels of virulence, suggesting that the RH:ΔNPT1 strain may represent a promising live-attenuated vaccine against toxoplasmosis, which is worthy of further evaluation in food-producing animals and in definitive feline host.https://www.frontiersin.org/article/10.3389/fmicb.2019.01875/fullToxoplasma gondiiRH:ΔNPT1immunizationlive-attenuated vaccinemice
spellingShingle Wen-Bin Yang
Wen-Bin Yang
Wen-Bin Yang
Jin-Lei Wang
Qian Gui
Yang Zou
Kai Chen
Qing Liu
Qin-Li Liang
Xing-Quan Zhu
Xing-Quan Zhu
Dong-Hui Zhou
Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
Frontiers in Microbiology
Toxoplasma gondii
RH:ΔNPT1
immunization
live-attenuated vaccine
mice
title Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
title_full Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
title_fullStr Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
title_full_unstemmed Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
title_short Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
title_sort immunization with a live attenuated rh δnpt1 strain of toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice
topic Toxoplasma gondii
RH:ΔNPT1
immunization
live-attenuated vaccine
mice
url https://www.frontiersin.org/article/10.3389/fmicb.2019.01875/full
work_keys_str_mv AT wenbinyang immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT wenbinyang immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT wenbinyang immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT jinleiwang immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT qiangui immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT yangzou immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT kaichen immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT qingliu immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT qinliliang immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT xingquanzhu immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT xingquanzhu immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice
AT donghuizhou immunizationwithaliveattenuatedrhdnpt1strainoftoxoplasmagondiiinducesstrongprotectiveimmunityagainsttoxoplasmosisinmice